Vitamin D is essential for several physiological functions and biological processes. Increasing levels of maternal
vitamin D are required throughout pregnancy as a unique source of
vitamin D for the fetus, and consequently maternal
vitamin D deficiency may result in several adverse outcomes in newborns. However, the genetic regulation of
vitamin D in pregnancy and at birth is not yet well understood. We performed genome-wide association studies of maternal midgestational serum-derived and neonatal blood-spot-derived total
25-hydroxyvitamin D from a case-control study of
autism spectrum disorder (ASD). We identified one fetal locus (rs4588) significantly associated with neonatal
vitamin D levels in the GC gene, encoding the
binding protein for the transport and function of
vitamin D. We also found suggestive cross-associated loci for neonatal and maternal
vitamin D near immune genes, such as CXCL6-IL8 and ACKR1 We found no interactions with ASD. However, when including a set of cases with
intellectual disability but not ASD (N = 179), we observed a suggestive interaction between decreased levels of neonatal
vitamin D and a specific maternal genotype near the PKN2 gene. Our results suggest that genetic variation influences total
vitamin D levels during pregnancy and at birth via
proteins in the
vitamin D pathway, but also potentially via distinct mechanisms involving loci with known roles in immune function that might be involved in
vitamin D pathophysiology in pregnancy.